Williams Michael P, Manjourides Justin, Smith Louisa H, Rainer Crissi B, Hightow-Weidman Lisa, Haley Danielle F
Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
AIDS Behav. 2025 Aug 29. doi: 10.1007/s10461-025-04860-2.
While digital health interventions (DHIs) have become an increasingly common approach to address HIV vulnerability among young sexual and gender minority men who have sex with men (YSGMMSM), few studies consider the role of neighborhood disadvantage in DHI efficacy and engagement. The present study is a secondary data analysis of 212 YSGMMSM aged 16-24 that combined biological and clinical survey data from the primary efficacy randomized controlled trial (RCT) of P3, a PrEP adherence DHI, with a measure of neighborhood disadvantage to characterize P3 engagement and efficacy among high and low disadvantage neighborhoods. We found that participants residing in high disadvantage neighborhoods engaged with P3 a median of 63 days (IQR = 39-76), compared to 77 days (IQR = 51-82) in low disadvantage neighborhoods. Among those who received the P3 intervention, participants residing in high disadvantage neighborhoods had higher odds of PrEP non-adherence (OR = 3.6, CI = 1.2, 10.4). Further, we found that there was minimal difference in PrEP non-adherence rates among those residing high disadvantage neighborhoods between intervention and control groups (28% vs. 25%) compared to 9% in the intervention condition and 18% in the control condition among those residing in low disadvantage neighborhoods. Despite this, receiving the P3 intervention did not moderate the relationship between neighborhood disadvantage and PrEP non-adherence. These findings suggest that neighborhood disadvantage may play a role in PrEP adherence DHI efficacy and engagement among YSGMMSM. Further research is needed to quantify the role of neighborhood disadvantage in YSGMMSM using HIV DHIs.
虽然数字健康干预措施(DHIs)已成为解决男男性行为的年轻性少数和性别少数男性(YSGMMSM)中艾滋病毒易感性问题的一种越来越常见的方法,但很少有研究考虑社区劣势在数字健康干预措施的效果和参与度方面所起的作用。本研究是对212名年龄在16至24岁之间的男男性行为的年轻性少数和性别少数男性进行的二次数据分析,该分析将来自PrEP依从性数字健康干预措施P3的主要疗效随机对照试验(RCT)的生物学和临床调查数据与一项社区劣势衡量指标相结合,以描述高劣势社区和低劣势社区中P3的参与度和效果。我们发现,居住在高劣势社区的参与者使用P3的时间中位数为63天(四分位距=39-76),而居住在低劣势社区的参与者为77天(四分位距=51-82)。在接受P3干预的人群中,居住在高劣势社区的参与者PrEP不依从的几率更高(比值比=3.6,置信区间=1.2, 10.4)。此外,我们发现,与居住在低劣势社区的参与者相比,居住在高劣势社区的干预组和对照组之间PrEP不依从率的差异极小(28%对25%),而居住在低劣势社区的参与者中,干预组的这一比例为9%,对照组为18%。尽管如此,接受P3干预并没有缓和社区劣势与PrEP不依从之间的关系。这些发现表明,社区劣势可能在男男性行为的年轻性少数和性别少数男性中PrEP依从性数字健康干预措施的效果和参与度方面发挥作用。需要进一步的研究来量化社区劣势在使用艾滋病毒数字健康干预措施的男男性行为的年轻性少数和性别少数男性中所起的作用。
Cochrane Database Syst Rev. 2008-7-16
JAMA Psychiatry. 2024-2-1
Int J STD AIDS. 2025-2
Rev Bras Enferm. 2023
Clin Pharmacol Ther. 2023-4